Selective inhibitor of the Rho-associated protein kinasep160ROCKlicense from Mitsubishi Pharma Corporation.
References
1. Uehata, M., et al., Nature, 389, 990-994 (1997).
2. Takahara, A., et al., Eur. J. Pharmacol., 460, 51-57 (2003).
3. Shimokawa, H.J., Cardiovasc